ACE2 and acute respiratory distress syndrome: More recent data analysis of 2 million people reported that taking ARBs and ACEi rather suppressed the aggravation of COVID-19 (33), supporting our first genetic mapping studies that ACE2 positively affects prevention from the pathology of ARDS.